Adolescents and adults diagnosed with fragile X syndrome (FXS) showed improvement in social gaze behavior — measured by their ability…
Articles by Patricia Inácio, PhD
Fragile X syndrome is among the four rare genetic disorders to be included in the world’s largest newborn screening study…
Weekly infusions with allopregnanolone, a natural brain steroid, for up to 12 weeks may help enhance levels of the GABA…
Zynerba Pharmaceuticals’ investigative therapy ZYN002 — a pharmaceutically produced cannabidiol (CBD) gel — was seen to significantly improve behavioral symptoms…
Zynerba Pharmaceuticals has launched a pivotal Phase 3 clinical trial, called CONNECT-FX, that will assess the safety and effectiveness of…
Children with fragile X syndrome exhibit abnormal gesture use (a form of non-verbal communication) early in development, partially accounting for autism…
Scientists have developed a new technique for genetic testing that can predict a woman’s risk of having a child with…
The FRAXA Research Foundation has awarded two $90,000 grants to university research projects that aim to identify new targets for…
Originally approved for hypertension, the injectable medicine bumetanide was able to correct an imbalance in nerve cells that underlies sensory problems…
Interventional strategies that foster the development of academic and living skills are necessary to assure the independence of adult fragile…